Research Paper Volume 15, Issue 22 pp 12927—12951
A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma
Figure 8. IC50 of six drugs between low-risk and high-risk groups. (A) The high-risk group exhibited more sensitivity to the four drugs compared to the low-risk group. (B) The high-risk group exhibited less sensitivity to the two drugs compared to the low-risk group.